Specialties

In part 3, the conclusion of this Exclusive Interview, Grenye O'Malley talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the unique aspects of a new trial that studies the artificial pancreas and the benefits for people on multiple daily injections who may not want to use a pump.

ADA 2018 abstracts of interest include Entresto for the Treatment of Diabetic Peripheral Neuropathy; Oral Contraceptive Associated with Postmenopausal Diabetes; Glucokinase as Adjunct Therapy in People with Type 1 Diabetes, and more.

Restoring Insulin Secretion (RISE) Pediatric Medication Study shows that youth have markedly reduced insulin sensitivity and respond differently to medications.

Childhood overweight is associated with an increased risk of type 2 diabetes in adulthood.

Discrepancies prompt additional analyses of ACCORD-BP and SPRINT studies to determine best blood pressure target for those with diabetes.

Elevated BP readings at the doctor’s office linked to higher mortality than for those with consistently normal blood pressure.

Pooled analysis from two randomized trials shows significant differences in effects on two groups.

Study looks at whether intensive BP lowering can increase the risk of CKD.

High blood pressure and prediabetes together may do more harm to the body than either one alone.

Medication use may be associated with increased risk of mortality.